Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Atherectomy is a minimally invasive intervention that removes plaque from vessels. Atherectomy Devices have been developed to facilitate this technique, to cut the plaque from the artery walls using orbital, rotational, laser, and directional techniques. GlobalData uses proprietary data and analytics to provide a comprehensive report on the atherectomy devices devices market, including market shares of different players within Norway. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the atherectomy devices market in Norway was Boston Scientific followed by Becton Dickinson and Co, Koninklijke Philips, Cardiovascular Systems, Medtronic, AngioDynamics and Avinger.
Atherectomy is used in eliminating highly calcified plaque. Atherectomy interventions may be used for coronary and peripheral vessels to open a blockage and restore blood flow and it can be combined with angioplasty and stenting. Coronary Atherectomy Devices and Lower Extremity Peripheral Atherectomy Devices are covered. Coronary Atherectomy Devices include Coronary Rotational Atherectomy Devices, Coronary Directional Atherectomy Devices, Coronary Orbital Atherectomy Devices and Coronary Laser Atherectomy Devices. Lower Extremity Peripheral Atherectomy Devices include Peripheral Rotational Atherectomy Devices, Peripheral Directional Atherectomy Devices, Peripheral Orbital Atherectomy Devices and Peripheral Laser Atherectomy Devices.
The value of the atherectomy devices devices market within Norway was expected to be over $0.8m in 2023.
For the latest complete market share analysis of atherectomy devices device market in Norway, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
